VIVS vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 25, 2026

VIVS

52.6
AI Score
VS
VIVS Wins

CLYM

51.5
AI Score

Investment Advisor Scores

VIVS

53score
Recommendation
HOLD

CLYM

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric VIVS CLYM Winner
Net Income -13.84M -13.72M CLYM
Operating Income -11.49M -15.21M VIVS
ROE 1259.6% -9.3% VIVS
ROA -187.4% -9.0% CLYM
Total Assets 7.39M 152.37M CLYM
Cash 5.02M 8.36M CLYM
Current Ratio 2.38 27.86 CLYM

Relative Price Performance (Last 90 Days)

VIVS 1M: -65.9% · 3M: -76.8% CLYM 1M: -8.4% · 3M: +32.5%

Current Technical Phase

VIVS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -25.7%), weak momentum, RSI 20

RSI (14): 20.1 · Price: $0.33

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 42.2 · Price: $11.81

Fundamentals Snapshot

Metric VIVS CLYM
Market Cap
Forward P/E 0.0 -10.4
Trailing P/E
Revenue (TTM)
Revenue Growth -0.2% 0.0%
Gross Margin -31.0%
Operating Margin -79.7% 0.0%
EPS -5.32 -0.77
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, VIVS is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.